Stock Price Forecast

April 26, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Rallybio Corp chart...

About the Company

We do not have any company description for Rallybio Corp at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

48

Exchange

Nasdaq

$38M

Total Revenue

48

Employees

$64M

Market Capitalization

-0.93

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $RLYB News

Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket

on MSN ago, source:

Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a ...

Rare Disease-Focused Rallybio Inks Development Pact With Johnson & Johnson, Stock Shoots Higher

on MSN ago, source:

Rallybio partners with Johnson & Johnson to develop therapies targeting fetal and neonatal alloimmune thrombocytopenia, ...

Rallybio (RLYB) Price Target Decreased by 16.00% to 12.85

9d ago, source: Fintel on MSN

The average one-year price target for Rallybio (NasdaqGS:RLYB) has been revised to 12.85 / share. This is an decrease of ...

Buy Rating Affirmed for Rallybio Amid Significant Market Opportunity in FNAIT Treatment

8d ago, source:

Rallybio (RLYB – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jonathan Wolleben ...

RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up

14d ago, source:

RallyBio (RLYB) gains 83% after announcing a collaboration deal with J&J to develop novel therapies to reduce the risk of FNAIT in pregnant women, along with funding of $6.6 million from the latter.

Analyzing the Price-to-Earnings Ratio of Rallybio Corp (RLYB)

5mon ago, source: newsheater

H.C. Wainwright, on the other hand, stated in their research note that they expect to see RLYB reach a price target of $18. The rating they have provided for RLYB stocks is “Buy” according to the ...

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

15d ago, source:

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

FNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting

9d ago, source:

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the ...

Stock Index Futures are Higher after Wholesale Prices Increased Less Than Expected in March

15d ago, source: Barchart on MSN

S&P 500 E-Mini futures (ESM24)are up 0.02%, and June Nasdaq 100 E-Mini futures (NQM24) are up 0.17% this morning, after the release of this morning's inflation data.  The Producer Price Index (PPI), ...

These Are The Stocks To Watch Today

14d ago, source: InvestingChannel on MSN

Rallybio, Nikola, Ginkgo Bioworks, and AMD <li /> JPMorgan Chase Earnings Beat Forecasts On Top And Bottom Lines <li ...

Amazon Adds A.I. Expert To Board Of Directors

14d ago, source: InvestingChannel on MSN

E-commerce giant Amazon (AMZN) has added computer scientist and artificial intelligence (A.I.) expert Andrew Ng to its board of directors. Ng previously led A.I. projects at Google parent company ...

Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket

on MSN ago, source:

Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...